Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Calculi | 12 | 2024 | 341 | 6.200 |
Why?
|
| Calcium Oxalate | 6 | 2024 | 186 | 2.030 |
Why?
|
| Calcium Phosphates | 3 | 2024 | 77 | 1.360 |
Why?
|
| Oxalates | 3 | 2023 | 48 | 1.030 |
Why?
|
| Fructose | 1 | 2024 | 36 | 0.950 |
Why?
|
| Calcium | 4 | 2023 | 1172 | 0.940 |
Why?
|
| Sodium, Dietary | 1 | 2022 | 8 | 0.860 |
Why?
|
| Hyperoxaluria | 1 | 2022 | 26 | 0.830 |
Why?
|
| Citric Acid | 1 | 2021 | 38 | 0.770 |
Why?
|
| Diphosphonates | 2 | 2021 | 36 | 0.770 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2021 | 33 | 0.740 |
Why?
|
| Gastric Bypass | 1 | 2021 | 110 | 0.690 |
Why?
|
| Nurses | 2 | 2017 | 40 | 0.680 |
Why?
|
| Bariatric Surgery | 1 | 2020 | 195 | 0.610 |
Why?
|
| Postmenopause | 1 | 2018 | 102 | 0.600 |
Why?
|
| Uric Acid | 1 | 2017 | 136 | 0.580 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 46 | 0.560 |
Why?
|
| Nephrolithiasis | 1 | 2016 | 23 | 0.540 |
Why?
|
| Bone Density | 1 | 2017 | 209 | 0.530 |
Why?
|
| Urinalysis | 3 | 2021 | 31 | 0.490 |
Why?
|
| Incidence | 4 | 2020 | 1592 | 0.460 |
Why?
|
| Risk Factors | 5 | 2021 | 5466 | 0.400 |
Why?
|
| Patient Handoff | 4 | 2014 | 95 | 0.400 |
Why?
|
| Creatinine | 2 | 2021 | 293 | 0.360 |
Why?
|
| Prospective Studies | 5 | 2021 | 4273 | 0.350 |
Why?
|
| Humans | 20 | 2024 | 89073 | 0.330 |
Why?
|
| Linear Models | 2 | 2021 | 421 | 0.310 |
Why?
|
| Middle Aged | 10 | 2021 | 25865 | 0.290 |
Why?
|
| Female | 13 | 2024 | 46014 | 0.270 |
Why?
|
| Sex Factors | 2 | 2021 | 1063 | 0.270 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 848 | 0.250 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 988 | 0.250 |
Why?
|
| Sucrose | 1 | 2024 | 65 | 0.230 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2023 | 14 | 0.230 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 64 | 0.230 |
Why?
|
| Hypercalciuria | 1 | 2023 | 47 | 0.220 |
Why?
|
| Magnesium | 1 | 2023 | 178 | 0.220 |
Why?
|
| Thiazides | 1 | 2022 | 16 | 0.210 |
Why?
|
| Alkalies | 1 | 2022 | 8 | 0.210 |
Why?
|
| Parathyroid Hormone | 1 | 2023 | 216 | 0.210 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 3657 | 0.200 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 1706 | 0.200 |
Why?
|
| Sodium | 1 | 2022 | 331 | 0.190 |
Why?
|
| Adult | 6 | 2024 | 26508 | 0.190 |
Why?
|
| Bicarbonates | 1 | 2021 | 58 | 0.190 |
Why?
|
| Internal Medicine | 3 | 2013 | 355 | 0.190 |
Why?
|
| Male | 9 | 2024 | 42254 | 0.190 |
Why?
|
| Preoperative Period | 1 | 2021 | 94 | 0.190 |
Why?
|
| Patient Safety | 2 | 2013 | 216 | 0.190 |
Why?
|
| Urine | 1 | 2021 | 89 | 0.180 |
Why?
|
| Glucose | 1 | 2023 | 630 | 0.180 |
Why?
|
| Symptom Assessment | 1 | 2020 | 66 | 0.180 |
Why?
|
| Antibody Formation | 1 | 2020 | 171 | 0.180 |
Why?
|
| Postoperative Period | 1 | 2021 | 301 | 0.180 |
Why?
|
| Carrier Proteins | 1 | 2023 | 681 | 0.170 |
Why?
|
| Time Factors | 3 | 2018 | 5320 | 0.170 |
Why?
|
| Internship and Residency | 3 | 2013 | 1041 | 0.170 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 309 | 0.160 |
Why?
|
| Premenopause | 1 | 2018 | 57 | 0.160 |
Why?
|
| Menopause | 1 | 2018 | 76 | 0.150 |
Why?
|
| Epidemiologic Studies | 1 | 2016 | 16 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1855 | 0.140 |
Why?
|
| United States | 3 | 2020 | 6957 | 0.130 |
Why?
|
| Self Report | 1 | 2017 | 295 | 0.130 |
Why?
|
| Body Size | 1 | 2016 | 91 | 0.130 |
Why?
|
| Women's Health | 1 | 2016 | 102 | 0.130 |
Why?
|
| Health Personnel | 1 | 2017 | 212 | 0.130 |
Why?
|
| Aged | 6 | 2020 | 19078 | 0.130 |
Why?
|
| Age Factors | 2 | 2018 | 1867 | 0.130 |
Why?
|
| Pamphlets | 1 | 2014 | 14 | 0.120 |
Why?
|
| Obesity | 1 | 2020 | 966 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2018 | 2863 | 0.110 |
Why?
|
| Diet | 1 | 2016 | 442 | 0.110 |
Why?
|
| Treatment Outcome | 2 | 2022 | 8203 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1067 | 0.110 |
Why?
|
| Continuity of Patient Care | 1 | 2014 | 172 | 0.110 |
Why?
|
| Physicians, Primary Care | 2 | 2012 | 105 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 207 | 0.100 |
Why?
|
| Patients | 1 | 2012 | 102 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 359 | 0.100 |
Why?
|
| Biomarkers | 1 | 2017 | 1755 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2018 | 2291 | 0.090 |
Why?
|
| Awareness | 1 | 2010 | 89 | 0.090 |
Why?
|
| Prognosis | 1 | 2017 | 3773 | 0.090 |
Why?
|
| Hospitalists | 1 | 2010 | 135 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2010 | 320 | 0.070 |
Why?
|
| Physicians | 1 | 2014 | 689 | 0.070 |
Why?
|
| Communication | 1 | 2010 | 457 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2010 | 625 | 0.060 |
Why?
|
| Phosphates | 1 | 2024 | 160 | 0.050 |
Why?
|
| Metabolomics | 1 | 2023 | 75 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2020 | 71 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 120 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 464 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2013 | 195 | 0.030 |
Why?
|
| Risk | 1 | 2012 | 657 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 225 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2010 | 118 | 0.020 |
Why?
|
| Frail Elderly | 1 | 2010 | 82 | 0.020 |
Why?
|
| Perception | 1 | 2010 | 178 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 329 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2010 | 291 | 0.020 |
Why?
|
| Chicago | 1 | 2013 | 1423 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 461 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2012 | 9003 | 0.010 |
Why?
|